Literature DB >> 18600447

Roles of glutathione (GSH) in dopamine (DA) oxidation studied by improved tandem HPLC plus ESI-MS.

Zhi Dong Zhou1, Tit Meng Lim.   

Abstract

In this study, new procedure with improved tandem HPLC plus ESI-MS was utilized to decipher the protective role of glutathione (GSH) against dopamine (DA) oxidation. We demonstrated that auto-oxidation of DA could produce aminochrome (AM, a cyclized DA quinone), which could be effectively abrogated by reductants, especially by GSH. Furthermore GSH was demonstrated to be able to conjugate with AM to form various conjugates via condensation reactions without enzymatic catalysis. The GSH-AM conjugates tend to aggregate, possibly mediated by conjugated AM structures, but could be inhibited by GSH. We hypothesized that proteins conjugated by AM might facilitate Lewy body formation of Parkinson's disease (PD) in dopaminergic neurons via similar polymerization. We proposed that GSH could protect dopaminergic neurons against DA-induced toxicity via various mechanisms. The imbalance between DA oxidation and GSH protective capacity could be a key factor contributing to PD. Strategies to use GSH analogues, GSH inducers or to control DA oxidation might work to control PD onset and development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600447     DOI: 10.1007/s11064-008-9778-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  20 in total

1.  Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis.

Authors:  A H Stokes; D Y Lewis; L H Lash; W G Jerome; K W Grant; M Aschner; K E Vrana
Journal:  Brain Res       Date:  2000-03-06       Impact factor: 3.252

2.  Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein.

Authors:  Masaki Kobayashi; Jihoon Kim; Natsuki Kobayashi; Sungwoong Han; Chikashi Nakamura; Kazunori Ikebukuro; Koji Sode
Journal:  Biochem Biophys Res Commun       Date:  2006-09-01       Impact factor: 3.575

3.  p-Quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly.

Authors:  Yasuhiko Izumi; Hideyuki Sawada; Noriko Sakka; Noriyuki Yamamoto; Toshiaki Kume; Hiroshi Katsuki; Shun Shimohama; Akinori Akaike
Journal:  J Neurosci Res       Date:  2005-03-15       Impact factor: 4.164

4.  Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinson's disease.

Authors:  J P Spencer; P Jenner; B Halliwell
Journal:  Neuroreport       Date:  1995-07-31       Impact factor: 1.837

Review 5.  Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation.

Authors:  Masato Asanuma; Ikuko Miyazaki
Journal:  Expert Rev Neurother       Date:  2006-09       Impact factor: 4.618

6.  Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.

Authors:  J P Spencer; P Jenner; S E Daniel; A J Lees; D C Marsden; B Halliwell
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

7.  Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase.

Authors:  Y Xu; A H Stokes; R Roskoski; K E Vrana
Journal:  J Neurosci Res       Date:  1998-12-01       Impact factor: 4.164

8.  Glutathione prevented dopamine-induced apoptosis of melanocytes and its signaling.

Authors:  Eun-Sang Park; So-Young Kim; Jung-Im Na; Hyo Sub Ryu; Sang-Woong Youn; Dong-Seok Kim; Hye-Young Yun; Kyoung-Chan Park
Journal:  J Dermatol Sci       Date:  2007-05-04       Impact factor: 4.563

9.  Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells.

Authors:  M Emdadul Haque; Masato Asanuma; Youichirou Higashi; Ikuko Miyazaki; Ken-ichi Tanaka; Norio Ogawa
Journal:  Biochim Biophys Acta       Date:  2003-01-02

10.  Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with alpha-synuclein.

Authors:  Marco Bisaglia; Stefano Mammi; Luigi Bubacco
Journal:  J Biol Chem       Date:  2007-03-29       Impact factor: 5.157

View more
  10 in total

1.  Glutathione conjugates with dopamine-derived quinones to form reactive or non-reactive glutathione-conjugates.

Authors:  Zhi Dong Zhou; Tit Meng Lim
Journal:  Neurochem Res       Date:  2010-08-19       Impact factor: 3.996

2.  The Therapeutic Implications of Tea Polyphenols Against Dopamine (DA) Neuron Degeneration in Parkinson's Disease (PD).

Authors:  Zhi Dong Zhou; Shao Ping Xie; Wuan Ting Saw; Patrick Ghim Hoe Ho; Hongyan Wang; Zhou Lei; Zhao Yi; Eng King Tan
Journal:  Cells       Date:  2019-08-16       Impact factor: 6.600

3.  Z-ligustilide potentiates the cytotoxicity of dopamine in rat dopaminergic PC12 cells.

Authors:  Hongyi Qi; Jia Zhao; Yifan Han; Allan S Y Lau; Jianhui Rong
Journal:  Neurotox Res       Date:  2012-03-27       Impact factor: 3.911

4.  Effect of Chronic Methylphenidate Treatment in a Female Experimental Model of Parkinsonism.

Authors:  Hannah V Oakes; David McWethy; Shannon Ketchem; Lily Tran; Kaitlyn Phillips; Laura Oakley; Richard J Smeyne; Brooks B Pond
Journal:  Neurotox Res       Date:  2021-03-05       Impact factor: 3.911

Review 5.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

Review 6.  Analysis of endogenous glutathione-adducts and their metabolites.

Authors:  Ian A Blair
Journal:  Biomed Chromatogr       Date:  2010-01       Impact factor: 1.902

Review 7.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

8.  Separation of intermediates of iron-catalyzed dopamine oxidation reactions using reversed-phase ion-pairing chromatography coupled in tandem with UV-visible and ESI-MS detections.

Authors:  Lin Zhang; Gargey Yagnik; Dianlu Jiang; Shuyun Shi; Peter Chang; Feimeng Zhou
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-10-29       Impact factor: 3.205

9.  Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson's disease through AKT/mTOR pathway.

Authors:  Liangqin Shi; Chao Huang; Qihui Luo; Yu Xia; Wentao Liu; Wen Zeng; Anchun Cheng; Riyi Shi; Chen Zhengli
Journal:  Aging (Albany NY)       Date:  2020-05-18       Impact factor: 5.682

10.  A Simple HPLC-UV Method for the Determination of Glutathione in PC-12 Cells.

Authors:  Raju N Appala; Sridevi Chigurupati; Raju V V S S Appala; Kesavanarayanan Krishnan Selvarajan; Jahidul Islam Mohammad
Journal:  Scientifica (Cairo)       Date:  2016-04-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.